Literature DB >> 631900

Assays of cephalosporin antibiotics administered prophylactically in open heart surgery. Determination of serum and tissue levels before, during and after cardiopulmonary bypass.

P Eigel, A Tschirkov, P Satter, H Knothe.   

Abstract

Twenty-eight patients who underwent open-heart surgery were divided into three groups, each of which received a different antibiotic from the cephalosporin series (cephalotin, cefazolin or cefamandole) in order to prevent infection. All antibiotics were given via intravenous infusion in a dosage of 2 g prior to surgery. To clarify the question of antibacterial activity under operative conditions with the cardiopulmonary bypass, the serum and tissue levels were determined before, during and after the surgical procedure. The effectiveness of the cephalosporins against bacteria most frequently encountered in open-heart surgery was demonstrated and substantiated by the serum and tissue concentrations. It became apparent that, in view of the favorable serum and tissue levels during and after the cardiopulmonary bypass, cefamandole should be considered the antibiotic of choice in preventing infections during open-heart surgery.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 631900     DOI: 10.1007/bf01641087

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  [Prevention using cephalothin in open-heart surgery].

Authors:  P Eigel; A Tschirkov; H Knothe; E Krause; P Satter
Journal:  Chirurg       Date:  1977-08       Impact factor: 0.955

2.  Prosthetic valve endocarditis. Analysis of 38 cases.

Authors:  W E Dismukes; A W Karchmer; M J Buckley; W G Austen; M N Swartz
Journal:  Circulation       Date:  1973-08       Impact factor: 29.690

3.  [Determination of cephalothin levels in human tissues].

Authors:  R Plaue; K Fabricius; S Wysocki
Journal:  Chirurg       Date:  1974-06       Impact factor: 0.955

4.  Cardiac surgery and bacterial endocarditis.

Authors:  M V Braimbridge
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

5.  Prosthetic valvular endocarditis. A 12-year review.

Authors:  L Slaughter; J E Morris; A Starr
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

Review 6.  The nature and prevention of prosthetic valve endocarditis.

Authors:  P D Stein; D E Harken; L Dexter
Journal:  Am Heart J       Date:  1966-03       Impact factor: 4.749

7.  Prosthetic valve endocarditis.

Authors:  P C Block; R W DeSanctis; A N Weinberg; W G Austen
Journal:  J Thorac Cardiovasc Surg       Date:  1970-10       Impact factor: 5.209

8.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

9.  Cephalothin prophylaxis assay during cardiopulmonary bypass.

Authors:  D J Williams; T W Steele
Journal:  J Thorac Cardiovasc Surg       Date:  1976-02       Impact factor: 5.209

  9 in total
  2 in total

1.  Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis.

Authors:  L M Baddour; M M Hill; A M Felty-Duckworth
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

2.  Randomized comparison of cefamandole, cefazolin, and cefuroxime prophylaxis in open-heart surgery.

Authors:  T G Slama; S J Sklar; J Misinski; S W Fess
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.